1) Welcome to a tweetorial on #insulinhesitancy in contemporary #T2D management. This serialized program is accredited for 0.5h by @academiccme: #physicians, #nurses, #pharmacists! I am @AliceYYCheng . . . Image
. . . and this educational activity is intended for healthcare providers and is supported by grants from AstraZeneca, Bayer, Chiesi, and NovoNordisk.
2) Let's start with a case. Meet Masika: 66 year old non-frail woman with #T2D x 15 yrs , MI 2 yrs ago, hypertension, no heart failure, otherwise well. On metformin, #GLP1-RA, #SGLT2i, sulfonylurea. BMI 30 kg/m2, A1c 7.9%, eGFR 66, normal ACR, LDL at target.
3) What is the target A1c that you would discuss with Masika?
a) ≤6.5% (48 mmol/mol)
b) ≤7.0% (53 mmol/mol)
c) 7.1-8.0% (54-64 mmol/mol)
d) ≥8.1% (65 mmol/mol)
4) Consistent with guidelines from around the world, it would be appropriate to target A1c ≤7% (choice b), given that she is non-frail. @DiabetesCanada Image
5) … and the reduction in microvascular and macrovascular complications that she can derive from the lower A1c Image
Image
6) What is the next appropriate antihyperglycemic therapy to offer her to lower the glucose levels?
a)Basal insulin
b)Premixed insulin
c)Bolus insulin
d)Fixed ratio combination of GLP-1RA + basal insulin
8) Welcome back to our tweetorial on #insulinhesitancy in contemporary #T2D management. The best learning is incremental--and so are serialized #tweetorials! I am @AliceYYCheng. Hello @MedTweetorials #NephTwitter
9) After #GLP-1RA, add basal insulin or transition to fixed ratio combo of GLP-1RA + basal insulin. Consistent with consensus algorithm from @AmDiabetesAssn @EASDnews. 4T study (DOI: 10.1056/NEJMoa075392) . . .
10) . . . showed that basal start had less hypoglycemia and weight gain compared to other insulin regimens Image
11) Despite advances in insulin, initiation still is often delayed by many yrs. Why?
a) System-related factors (low access, lack of time)
b) Provider factors (lack of time/experience, inertia)
c) Patient factors (fear of insulin, stigma, fear of wgt gain)
d) All of the above
12) Correct answer: D – all of the above. Image
13) Delaying advancement of therapy by 1 yr is associated with the loss of ~13,390 life-yrs and increased cost of USD 7.3 billion (1-yr time horizon, see DOI: 10.1007/s12325-019-01199-8). What can we do to address this inertia?
14) Educate ourselves – as you are doing now. Know Who, What and How of insulin use in type 2 diabetes. Here’s the “Who”. Image
15) Here’s the “what”. All available insulins can be classified as Bolus (mealtime), Basal or Premixed. Here is a VERY handy insulin prescription tool from @DiabetesCanada . . .
16) . . . that has made one of the hard parts (prescription) easier. Page 2 has the insulin start & titration “cheat sheet” diabetes.ca/DiabetesCanada…
17) For the “How”, we need to self-reflect. The negative perception of insulin often comes from us. Insulin = “replacement” therapy. It is not punishment or threat. It is not the end of the road.
18) Ask and listen to patient’s concerns. Show the insulin delivery systems. Consider a “dry injection” in office. This will go far to allay fears.
19) Do not get hung up on the starting dose of insulin. It will be wrong! It is ALL ABOUT THE TITRATION. If you are not going to titrate, do not bother starting. Usual basal starting dose is 10 units or 0.2 units/kg. #Titration is the key!
20) Who should be the primary person(s) to titrate the insulin?
22) Welcome back! Let's wrap this up. THANK YOU for following us for Twitter-delivered CE/#CME. Credits available also in Canada, GB, and EU--all FREE. I am @AliceYYCheng and I left you with a question yesterday!
23) Self-titration by person w/#diabetes is as effective (or more) than HCP-led. If glucose testing is available, teach self-titration of basal insulin using simple algorithm. In Canada, we increase by 1 unit daily until fasting glucose target reached guidelines.diabetes.ca/docs/cpg/Appen… Image
24) Pro tip: when teaching self-titration, give context – starting at low dose, will likely need 50-60 units to reach target. This gives context so person more likely to keep titrating.
25) Successful titration requires ongoing support from interprofessional providers - always involve #diabetes education team (nurse, #dietitian, pharmacist etc)
26) Inadequate titration continues to be a barrier even when people are started on insulin as evidenced by the markedly reduced proportion of people w/#T2D achieving A1c <7% on insulin. More work needs to be done! Image
27) Final thoughts: Words matter (frame insulin properly from diagnosis). Basal insulin is preferred start in #T2D. The starting dose will always be wrong. Titration is the key. Empower the person living w/#diabetes to self-titrate.
28) That's it! You made it! Free CE/#CME! #Physicians, #nurses, #pharmacists: go to cardiometabolic-ce.com/insulin2 and claim your credit! I am @AliceYYCheng. Follow us for more tweetorials! #Medtwitter #MedEd @MedTweetorials @CardioNerds

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with cardio-met

cardio-met Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @cardiomet_CE

7 Oct
Welcome to our final Goggledocs tweetorial from this #EASD2021 takeover!
Over the last few days we have discussed all things cardio-reno-metabolic including SGLT2s, GLP1s, dual agonists, triple agonists….but not mentioned much about type 1 diabetes…
So today we are going to end on a cardiometabolic focused look at Type 1 Diabetes with data from #EASD2021 interwoven in... stay tuned!
One of the key sessions and guidance from @EASDnews #EASD2021 was the formalized joint ADA-EASD consesnsus report for management of type 1 diabetes… care.diabetesjournals.org/content/early/…
Read 58 tweets
6 Oct
The @GoggleDocs takeover of @cardiomet_CE continues!

We are 4 UK 🇬🇧 based doctors working across primary & secondary healthcare

Our interests are "what's new, and meaningful, in cardiorenal metabolic medicine"

Check out our YouTube channel youtube.com/c/GoggleDocs Image
Yesterday we had key messages from ReTune & diabetes remission & TriMASTER exploring “what next after metformin?”

Today @GoggleDocs will take you through some SGLT2 inhibitor highlights from #EASD2021 - the gift that keeps on giving!
Let’s start with some history!

SGLT2 inhibitors were originally developed from natural compounds found in what?
Read 29 tweets
6 Oct
Yes it's the @GoggleDocs as we continue our #takeover of the @cardiomet_CE account.

Reporting some of the things that interested us in the recent #EASD2021

Please check out our previous mini-tweetorials.

@EASDnews @EASDelearning @ADA_DiabetesPro
Thus far we have covered...

▶️ Latest data on tirzepatide (GIP/GLP-1 dual agonist)✅
▶️ "Triple G" - a new GIP/GLP-1/Glucagon agonist✅
▶️ Remission in non-obese #type2diabetes

Next up is "what's next after metformin?" - what the GRADE & TriMaster Studies add Image
Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE)

📍Presented an update at the #EASD2021 , although little changed from the #ADA2021 presentation.

Please check out one of our own @GoggleDocs posts at the time

Read 13 tweets
5 Oct
Time for a shit in gear as the @GoggleDocs continue their £takeover of the @cardiomet_CE account.

From treatments that are still in the development stage now back to basics.

In this mini-thread today we are going to cover a couple of sessions from #EASD2021 that caught our 👁️
First up led by Prof. Roy Taylor of @UniofNewcastle in collaboration with the @UniofOxford Diabetes Trial Unit.

You may remember Prof. Taylor from the seminal DiRECT Study 👉directclinicaltrial.org.uk

Today I will be going through some of the preliminary data from the ReTune Study Image
📍Twin Cycle Hypothesis (R. Tayor 2008) of #type2diabetes
📍Once an individual' subcutaneous fat reserves are full
▶️ Fat is stored in the liver
▶️ Liver derived VLDL in turn, among other things, ⤴️ pancreatic fat
▶️⤴️pancreatic fat leads onto ⤵️ insulin secretion to food Image
Read 11 tweets
4 Oct
It's Monday and time for us @GoggleDocs to #takeover the @cardiomet_CE account for the next few days.

It's time to revisit the recent #EASD2021 conference.

Highlights in what's new in
#T1D
#type2diabetes
#NAFLD
#CKD
#HeartFailure
Just to remind you guys

The @GoggleDocs are a bunch of 🇬🇧 docs/🤓 who are fascinated about the cardio-metabolic conditions we are increasingly managing.

Please check out our @YouTube channel
youtube.com/channel/UC8Tzu…
This accredited educational program is intended for healthcare providers only, and is supported by grants from AstraZeneca, Bayer, Chiesi, and NovoNordisk. Follow this thread for a link to credit. CE/#CME credit for #physicians, #nurses, #pharmacists in US, Canada, GB, EU.
Read 22 tweets
10 Sep
STEP this way for the last of our tweetorials covering #ESCCongress @escardio Looking at a trial of intensive blood pressure control in older adults with hypertension
First...step aside to a different STEP trial – Semaglutide in Obesity – our last tweetorial on this was very popular – have a look!
Now step forward to this tweetorial on BP lowering…
Read 38 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!

Follow Us on Twitter!

:(